Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years
23 agosto 2013 aggiornato da: Wales Cancer Trials Unit
A Pilot Clinical Trial Looking at the Effect on Lung Cancer Diagnosis of Giving a CXR to Smokers Aged Over 60 With Chest Symptoms
RATIONALE: Diagnostic procedures, such as an urgent chest x-ray, may help in planning cancer treatment. It is not yet known whether standard medical care is more effective than an urgent x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years.
PURPOSE: This randomized clinical trial is studying standard medical care to see how well it works compared with an urgent chest x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years.
Panoramica dello studio
Stato
Sconosciuto
Condizioni
Descrizione dettagliata
OBJECTIVES:
Primary
- To determine the prevalence of extra-NICE symptoms in patients consulting in UK general practice.
- To determine the proportion of patients who agree to participate in the trial.
- To determine the proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers.
Secondary
- To determine the best way to train general practitioners to identify and recruit eligible patients into the trial.
- To determine the most effective method of presenting the trial (and randomization) to patients.
- To determine the barriers to recruitment and how to overcome those barriers.
- To determine the best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays.
- To determine the best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'.
- To determine the stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer.
OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms.
- Arm A: Patients are managed as per the National Institute for Health and Clinical Excellence (NICE) guidelines.
- Arm B: Patients are referred for an urgent chest x-ray according to extra-NICE guidelines.
General practitioners from South East Wales are surveyed to assess their level of interest in the proposed full trial. For the feasibility study, 20 South East Wales general practices and 6 South Yorkshire general practices are selected. General practitioners are trained to recruit all patients who fulfill the extra-NICE criteria as well as those who do not.
Patients complete questionnaires (HADS, EQ-5D, and ICECAP[O]) at baseline and at 2 months to measure quality of life and health economic analysis of the cost-effectiveness of extra-NICE guidelines.
Peer Reviewed and Funded or Endorsed by Cancer Research UK.
Tipo di studio
Interventistico
Iscrizione (Anticipato)
386
Fase
- Non applicabile
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
60 anni e precedenti (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
DISEASE CHARACTERISTICS:
- Patients over 60 seeing a participating General Practitioner
Currently smokes 10 or more pack years, meeting at least one of the following criteria:
- New or altered cough of any duration reported to primary care
- Increased breathlessness or wheezing (with or without purulent sputum)
Do not qualify for an urgent referral for a chest x-ray under the National Institute for Health and Clinical Excellence (NICE) guidelines (i.e., hemoptysis or unexplained or persistent [lasting > 3 weeks] signs or symptoms), including having any of the following:
- Cough
- Chest/shoulder pain
- Dyspnea
- Weight loss
- Chest signs
- Hoarseness
- Finger clubbing
- Features suggestive of metastasis from a lung cancer (e.g., in the brain, bone, liver, or skin)
- Cervical/supraclavicular lymphadenopathy
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- No chest x-ray within in past 3 months
- No need for a chest x-ray within the next 3 weeks for reasons other than those listed under Disease Characteristics
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Diagnostico
- Assegnazione: Randomizzato
- Mascheramento: Nessuno (etichetta aperta)
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
|---|
|
Prevalence of extra-NICE symptoms in patients consulting in UK general practice
|
|
Proportion of patients who agree to participate in the trial
|
|
Proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers
|
Misure di risultato secondarie
Misura del risultato |
|---|
|
Best way to train general practitioners to identify and recruit eligible patients into the trial
|
|
Most effective method of presenting the trial (and randomization) to patients
|
|
Barriers to recruitment and how to overcome those barriers
|
|
Best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays
|
|
Best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'
|
|
Stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer
|
|
False-positive and false-negative rates for chest x-rays
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Investigatore principale: Richard Neal, MD, North Wales Clinical School
Pubblicazioni e link utili
La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.
Pubblicazioni generali
- Prout H, Tod A, Neal R, Nelson A. Maximising recruitment of research participants into a general practice based randomised controlled trial concerning lung diagnosis-staff insights from an embedded qualitative study. Trials. 2022 Mar 21;23(1):225. doi: 10.1186/s13063-022-06125-y.
- Prout HC, Barham A, Bongard E, Tudor-Edwards R, Griffiths G, Hamilton W, Harrop E, Hood K, Hurt CN, Nelson R, Porter C, Roberts K, Rogers T, Thomas-Jones E, Tod A, Yeo ST, Neal RD, Nelson A. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials. 2018 Aug 4;19(1):419. doi: 10.1186/s13063-018-2803-4.
- Neal RD, Barham A, Bongard E, Edwards RT, Fitzgibbon J, Griffiths G, Hamilton W, Hood K, Nelson A, Parker D, Porter C, Prout H, Roberts K, Rogers T, Thomas-Jones E, Tod A, Yeo ST, Hurt CN. Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. Br J Cancer. 2017 Jan;116(3):293-302. doi: 10.1038/bjc.2016.414. Epub 2017 Jan 10.
- Hurt CN, Roberts K, Rogers TK, Griffiths GO, Hood K, Prout H, Nelson A, Fitzgibbon J, Barham A, Thomas-Jones E, Edwards RT, Yeo ST, Hamilton W, Tod A, Neal RD. A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial. Trials. 2013 Nov 26;14:405. doi: 10.1186/1745-6215-14-405.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio
1 giugno 2011
Completamento primario (Anticipato)
1 giugno 2013
Date di iscrizione allo studio
Primo inviato
27 aprile 2011
Primo inviato che soddisfa i criteri di controllo qualità
27 aprile 2011
Primo Inserito (Stima)
28 aprile 2011
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
26 agosto 2013
Ultimo aggiornamento inviato che soddisfa i criteri QC
23 agosto 2013
Ultimo verificato
1 aprile 2011
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- CDR0000699222
- WCTU-EL-CID
- EU-21112
- CRUK-C8350/A12199
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su somministrazione del questionario
-
Virginia Commonwealth UniversityRigel PharmaceuticalsReclutamentoLeucemia mieloide acutaStati Uniti
-
Cairn DiagnosticsCompletato
-
Nova Scotia Health AuthorityNon ancora reclutamento
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); Stanford University e altri collaboratoriReclutamentoMalaria | Plasmodium Vivax MalariaPerù
-
Pyae Linn AungUniversity of South Florida; Mahidol UniversityAttivo, non reclutanteMalaria | Plasmodium Vivax | Myanmar | Amministrazione farmaceutica di massa | PrimachinaBirmania
-
Brown UniversityCompletato
-
Universitas Negeri SemarangMinistry of Research, Technology and Higher Education, Republic of IndonesiaSconosciutoLo stress ossidativo | Sforzo; EccessoIndonesia
-
University Hospital PadovaCompletatoSindrome da distress respiratorio, neonatoItalia
-
Weill Medical College of Cornell UniversityNew York Presbyterian HospitalReclutamento
-
Washington University School of MedicineCompletatoFilariosi linfatica | Oncocercosi | Infezioni da elminti trasmessi dal suolo (STH).Liberia